CD4 and AIDS: When the World Health Organization (WHO) released the second edition of their consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, it recommended lifelong ART for all HIV/AIDS patients regardless of clinical status or CD4+ cell counts to reduce AIDS-related mortality [5].